NAFLD has been found to be associated with protein-coding sequence variation, including the I148M missense variant in PNPLA3 that compromises the individual’s ability to hydrolyse triglycerides [92]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.